Cannabis Use Disorder, Cannabis-Related Disorders, and Board Review (2025-2026 Recording)

Availability

On-Demand

Access expires on Nov 30, 2027

Cost

Member: $0.00

Non-Member: $39.00

This session provides a focused, case-based review of cannabis use disorder and related conditions across clinical settings, including epidemiology, pharmacology, and the endocannabinoid system, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.

What This Covers
• Epidemiology, patterns of use, and risk factors for cannabis use and cannabis-related disorders
• Pharmacology of cannabis and core concepts related to the endocannabinoid system
• Recognition and management of cannabis intoxication and withdrawal
• Associated clinical syndromes, including anxiety, psychosis, and sleep disturbances
• Screening strategies and diagnostic criteria for cannabis use disorder
• Current treatment approaches, including psychotherapy and emerging pharmacologic options
• Considerations related to evolving products, unregulated cannabinoids, and clinical decision-making across care settings

How This Resource Is Used
This session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.

Greg S. Swartzentruber, MD

Dr. Swartzentruber is an addiction medicine physician at UPMC (Harrisburg), where he serves as Addiction Medicine Fellowship Director. He is board certified in Addiction Medicine, Medical Toxicology, and Emergency Medicine and practices at the UPMC Center for Addiction Medicine.

He completed his medical degree at Penn State College of Medicine, followed by residency training in emergency medicine and fellowship training at UPMC, and is actively involved in the clinical management of patients with substance use disorders.

Alexa Golden, MD

Dr. Golden is an Addiction Medicine Fellow at UPMC (Harrisburg), where she is completing advanced clinical training in the management of substance use disorders.

To support a meaningful learning experience and recognize your participation:

The evaluation will become available after you have viewed the video in its entirety
We encourage you to complete the evaluation to reflect on the content and provide valuable feedback

Access Period
Access available through November 30, 2027 (aligned with the addiction medicine board exam cycle).

Recording Release Cycle
ACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.

Board Review Core Substances – Exam Access
Access to this recording extends beyond the standard annual cycle. Learners will retain access through November 30, 2027, aligned with the addiction medicine board examination cycle.